Cargando…
Screening of conventional anticonvulsants in a genetic mouse model of epilepsy
OBJECTIVE: Epilepsy is a common neurological disorder that affects 1% of the population. Approximately, 30% of individuals with epilepsy are refractory to treatment, highlighting the need for novel therapies. Conventional anticonvulsant screening relies predominantly on induced seizure models. Howev...
Autores principales: | Hawkins, Nicole A., Anderson, Lyndsey L., Gertler, Tracy S., Laux, Linda, George, Alfred L., Kearney, Jennifer A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5420810/ https://www.ncbi.nlm.nih.gov/pubmed/28491900 http://dx.doi.org/10.1002/acn3.413 |
Ejemplares similares
-
The Heat Sensing Trpv1 Receptor Is Not a Viable Anticonvulsant Drug Target in the Scn1a
(+/−) Mouse Model of Dravet Syndrome
por: Satpute Janve, Vaishali, et al.
Publicado: (2021) -
Staged anticonvulsant screening for chronic epilepsy
por: Berdichevsky, Yevgeny, et al.
Publicado: (2016) -
Pregnancy, epilepsy, and anticonvulsants
por: Steinhoff, Bernhard J
Publicado: (2008) -
Unexpected Efficacy of a Novel Sodium Channel Modulator in Dravet Syndrome
por: Anderson, Lyndsey L., et al.
Publicado: (2017) -
Fine Mapping of a Dravet Syndrome Modifier Locus on Mouse Chromosome 5 and Candidate Gene Analysis by RNA-Seq
por: Hawkins, Nicole A., et al.
Publicado: (2016)